Private Eyes on Janet Woodcock | GenomeWeb

Amphastar Pharmaceuticals hired a private detective firm to poke around in the lives of both Janet Woodcock, the director of FDA's Center for Drug Evaluation and Research, and Moheb Nasr, who is in charge of the Office of New Drug Quality Assessment, Politico reports. The company says it wanted to determine whether the officials were favoring its competitor, Momenta. The investigative firm Kroll, Politico reports, came up empty.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.